Kang Lab unravels novel therapeutic strategies for NLRC4-associated autoinflammation and infantile enterocolitis, a rare but often fatal monogenic disorder characterized by severe neonatal colitis, systemic hyperinflammation, and macrophage activation syndrome (MAS).

Featuring: Sudeep Ghimire, PhD; Zizhen Kang, PhD; Ashutosh Mangalam, PhD; Dawn Quelle, PhD; Anand Rajan KD, MBBS; Yuhang Wang, PhD